All SEC Filings :: Aurinia Pharmaceuticals Inc. (AUPH)

Filing Type:

Year:

Date	Form	Description	Pages
04/11/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	6
04/08/19	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Documents EX-99.1	19
03/19/19	40-F	Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4 Documents EX-99.1 EX-99.2 EX-99.3 EX-99.4 EX-99.5 EX-99.6	122
03/19/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	10
03/14/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	5
02/27/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	4
02/25/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	6
02/13/19	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	3
01/22/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	7
01/18/19	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities	7

All SEC Filings